Chlamydia pneumoniae – Respiratory PCR

Conformément au Règlement de l’Ontario 671/92 de la Loi sur les services en français, les renseignements d’analyses de laboratoire liés à la présente page ne sont offerts qu’en anglais parce qu’ils sont de nature scientifique ou technique et destinés uniquement à l’usage des fournisseurs de soins de santé qualifiés et non aux membres du public.

Background
This page provides testing information for Chlamydia pneumoniae from respiratory specimens using the Chlamydia pneumoniae - Respiratory PCR assay for at Public Health Ontario (PHO).

Chlamydia pneumonia is a causative agent of community-acquired pneumonia.

The following testing options are available for Chlamydia pneumoniae: PCR.

This page is for information specific to PCR Testing

Testing Indications

Acceptance/Rejection Criteria

Acceptable:

  • Use the recommended specimen collection kit (below)
  • Neat specimens acceptable (>=0.5ml)
  • Swab specimens must be collected with nylon flocculated swabs or on swabs with Dacron tips and aluminum or plastic shafts.

Unacceptable:

  • Swabs with calcium alginate or cotton tips and wooden sticks are not acceptable, as they have been shown to inhibit PCR.
  • Chemically fixed or preserved specimens are not acceptable for PCR testing and will be rejected upon receipt at PHO-Laboratory
  • Cobas PCR media is unacceptable as a transport media for Chlamydia pneumoniae.  Specimens sent in this media will be rejected.

For outbreaks contact Medical/Clinical Microbiologist at PHOL (Customer Service Center 1-877 604 4567).

Specimen Collection and Handling

Specimen Requirements

Test Requested Required Requisition(s) Specimen Type Minimum Volume Collection Kit

Chlamydia pneumoniae

Bronchoalveolar lavage

Nasopharyngeal Swab (NPS)

Throat swab

Tracheal aspirates

Respiratory tract specimens

  • Swab in universal transport media provided in kit
  • Neat (minimum volume 0.5mL)

Mycoplasma pneumoniae / Chlamydia pneumoniae PCR Kit; Kit Order# 390085

Requisition for Specimen Containers and Supplies

Submission and Collection Notes

1

Complete all fields of the requisition form, including:

  1. Test(s) requests and indications for testing
  2. Patient setting/population/source
  3. Symptoms
  4. Onset date
2

For clinical specimens, label the specimen container(s) with the patient’s first and last name, date of collection, and one other unique identifier such as the patient’s date of birth or Health Card Number. For additional information see: Criteria for Acceptance of Patient Specimens. Failure to provide this information may result in rejection or testing delay.

Timing of Specimen Collection

Specimens should be collected as soon as possible during the acute phase of the illness.

Storage and Transport

Specimens should be stored at 2-8°C following collection and shipped to PHO’s laboratory on ice packs

All clinical specimens must be shipped in accordance to the Transportation of Dangerous Good Act.

Label the container with two identifiers and place specimen in biohazard bag and seal.

Special Instructions

Specimens should be stored at 2-8°C following collection and shipped to PHO laboratory on ice packs.

Requisitions and Kit Ordering

Test Frequency and Turnaround Time (TAT)

Chlamydia pneumoniae is tested twice weekly at PHO – Laboratory -Toronto

TAT is up to 5 business days from receipt at PHO – Laboratory.

Contact Customer Service if a critical specimen is being submitted to ensure sample is run on next available run.

STAT and Critical Specimens Testing

Contact Customer Service if a critical specimen is being submitted to ensure sample is run on next available run.

Test Methods

Chlamydia pneumoniae specimens are tested by a PCR- Polymerase Chain Reaction test that detects Mycoplasma pneumoniae and Chlamydia pneumoniae. The PCR is >99% specific.

Interpretation

The following table provides possible test results with associated interpretations:

Result Interpretation Comments
Not Detected Chlamydia pneumoniae Not Detected Note: This specimen was tested using a laboratory test developed by Public Health Ontario Laboratory for the purpose of clinical testing. Results should be interpreted in the context of the clinical situation.
Detected Chlamydia pneumoniae  Detected Note: This specimen was tested using a laboratory test developed by Public Health Ontario Laboratory for the purpose of clinical testing. Results should be interpreted in the context of the clinical situation.
Invalid Chlamydia pneumoniae  Invalid Note: Nucleic Acid extraction and/or amplification could not be successfully completed.  This may be caused by inhibitory substances or improper sample collection.  Please resubmit if clinically relevant. This specimen was tested using a laboratory test developed by Public Health Ontario Laboratory for the purpose of clinical testing. Results should be interpreted in the context of the clinical situation.
Indeterminate Chlamydia pneumoniae Indeterminate Note: An indeterminate PCR test result may be due to a low level of target genetic material in the specimen content or a non-specific signal.  Please resubmit another specimen for testing if clinically indicated. This specimen was tested using a laboratory test developed by Public Health Ontario Laboratory for the purpose of clinical testing. Results should be interpreted in the context of the clinical situation.
Inconclusive Chlamydia pneumoniae Inconclusive Note: PCR results are inconclusive.  Consider collecting a second specimen for repeat PCR testing. This specimen was tested using a laboratory test developed by Public Health Ontario Laboratory for the purpose of clinical testing. Results should be interpreted in the context of the clinical situation.

Reporting

Results are reported to the physician, authorized health care provider (General O. Reg 45/22, s.18) or submitter as indicated on the requisition.

Mis à jour le 30 janv. 2024